InspireMD Announces Presentation of Positive One-Year
Data demonstrate lowest reported primary endpoint event rate of 1.95% through twelve months post-procedure for any carotid stent or embolic protection...
Source: globenewswire.com
System Vascular Chief News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from System Vascular Chief. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In System Vascular Chief Today - Breaking & Trending Today
InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024
TEL AVIV, Israel and MIAMI, March 26, 2024 -- InspireMD, Inc. , developer of the CGuard™ Embolic Prevention Stent System for the prevention of stroke, today announced that an abstract of the...
Source: marketscreener.com
InspireMD Presents Positive 30-Day Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial at VIVA23
TEL AVIV, Israel and MIAMI, Nov. 01, 2023 -- InspireMD, Inc. , developer of the CGuard™ Embolic Prevention Stent System for the prevention of stroke, today presented 30-day results from the...
Source: marketscreener.com